Related Experiment Video
Updated: May 19, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Immune memory and immune response in children from Bulgaria 5-15 years after primary hepatitis B vaccination
Pavel Teoharov1, Ani Kevorkyan, Nedyalka Petrova
1Department of Virology, National Centre of Infectious and Parasitic Diseases, Sofia, Bulgaria. teoharov.pavel@gmail.com
Insights
Hepatitis B vaccination in children provides lasting protection up to 15 years. Most children maintained protective antibodies, and all showed a strong immune memory response after a booster dose, indicating sustained immunity.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Bulgaria implemented universal infant hepatitis B vaccination in 1991.
- Limited studies have assessed long-term hepatitis B vaccine protection in children.
- This study aimed to evaluate the duration of protection in children post-vaccination.
Purpose of the Study:
- To investigate the duration of protection against hepatitis B in children aged 5-15 years after primary immunization.
- To measure the immune and anamnestic immune response.
- To identify any breakthrough hepatitis B infections.
Main Methods:
- 141 children (5-17 years) were grouped by time since primary immunization (approx. 5, 10, 15 years).
- Hepatitis B markers (HBsAg, anti-HBc, anti-HBs) were measured.
- A booster dose was given to children with anti-HBs <10 mIU/mL, with antibody levels assessed before and after.
Main Results:
- 67.4% of children had protective anti-HBs antibodies.
- Seroprotection rates were 84.6% (5 yrs), 55.8% (10 yrs), and 61.1% (15 yrs).
- 100% of children showed an anamnestic immune response after a booster dose, with GMC of 337.38 mIU/mL.
Conclusions:
- Recombinant hepatitis B vaccines induce long-term immune memory and protection in children.
- Immune memory persists for at least 15 years after primary infant immunization.
- The findings support the continued efficacy of infant hepatitis B vaccination programs.
Background:
Bulgaria adopted the World Health Organization recommendation of routine universal infant vaccination against hepatitis B in 1991. Nevertheless, only a few studies evaluated the protection after the vaccination against hepatitis B, especially in children. The objective of this study was to investigate the duration of protection against hepatitis B in children aged 5-15 years after primary immunization, by measuring the immune and anamnestic immune response and possible breakthrough infections.
Methods:
A total of 141 children (aged 5-17 years) were recruited randomly and divided into 3 groups, approximately 5 years (group 1), 10 years (group 2) and 15 years (group 3) after primary immunization with a recombinant hepatitis B vaccine; they were tested for hepatitis B markers: hepatitis B surface antigen anti-hepatitis core antibody and antibodies to hepatitis B surface antigen (anti-HB). A booster dose of vaccine was administered to 23 children with titers of anti-HBs antibodies below the threshold considered to be protective (<10 mIU/mL). Anti-HBs concentrations and geometric mean concentration (GMC) were determined before and 21-28 days after the booster vaccination.
Results:
Protective anti-HBs antibodies were detected in 95 of 141 (67.4 %) tested children, with a GMC of 63.57 mIU/mL. The seroprotection rate and GMC by groups was respectively: 84.6% and GMC of 76.05 mIU/mL in group 1; 55.8% and GMC of 58.1 mIU/mL in group 2; and 61.1% and GMC of 50.33 mIU/mL in group 3. Hepatitis B surface antigen and anti-hepatitis core antibody were found in 1 of the 141 subjects (0.7%). Of the remaining 140 children, 95 had anti-HBs ≥10 mIU/mL, and anti-hepatitis core antibodies were not detected. A booster dose of hepatitis B vaccine was administered to 23 of 45 (51%) children with anti-HBs <10 mIU/mL. Anamnestic immune response was shown in 100% of the children: the GMC was 337.38 mIU/mL and protective antibodies ranged between 15 and 955 mIU/mL.
Conclusion:
The study demonstrates the presence of immune memory and protection 5-15 years after the initial course of newborn immunization with recombinant vaccines against hepatitis B.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
15:57Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
Related Concept Videos
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccines
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...